The short version
11 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
naproxen sodium pm
diphenhydramine hydrochloride, naproxen sodium · DIPHENHYDRAMINE HYDROCHLORIDE 25 mg/1; NAPROXEN SODIUM 220 mg/1 · Tablet, Film Coated · Oral · H E B
NDC 37808-0264-27 · 1 BOTTLE in 1 CARTON / 80 TABLET, FILM COATED in 1 BOTTLE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- ANDA208499
- TE code
- —
- Approval date
- May 10, 2019
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of diphenhydramine hydrochloride, naproxen sodium (Tablet, Film Coated)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Amazon.com Services LLC | DIPHENHYDRAMINE HYDROCHLORIDE 25 mg/1; NAPROXEN SODIUM 220 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| American Sales Company | DIPHENHYDRAMINE HYDROCHLORIDE 25 mg/1; NAPROXEN SODIUM 220 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Dolgencorp Inc | DIPHENHYDRAMINE HYDROCHLORIDE 25 mg/1; NAPROXEN SODIUM 220 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| H E B | DIPHENHYDRAMINE HYDROCHLORIDE 25 mg/1; NAPROXEN SODIUM 220 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| L. Perrigo Company | DIPHENHYDRAMINE HYDROCHLORIDE 25 mg/1; NAPROXEN SODIUM 220 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Meijer Distribution Inc | DIPHENHYDRAMINE HYDROCHLORIDE 25 mg/1; NAPROXEN SODIUM 220 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Safeway | DIPHENHYDRAMINE HYDROCHLORIDE 25 mg/1; NAPROXEN SODIUM 220 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Target Corporation | DIPHENHYDRAMINE HYDROCHLORIDE 25 mg/1; NAPROXEN SODIUM 220 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Topco Associates LLC | DIPHENHYDRAMINE HYDROCHLORIDE 25 mg/1; NAPROXEN SODIUM 220 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| United Natural Foods, Inc. dba UNFI | DIPHENHYDRAMINE HYDROCHLORIDE 25 mg/1; NAPROXEN SODIUM 220 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Walgreen Company | DIPHENHYDRAMINE HYDROCHLORIDE 25 mg/1; NAPROXEN SODIUM 220 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "naproxen sodium pm — NDC 37808-0264-27," retrieved September 3, 2026, https://drugdashboards.com/drug/37808026427.
Free to cite with attribution — see how the data is put together.